Cannae (CNNE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Strategic transformation since February 2024 has shifted the portfolio from public to proprietary private investments, aiming for long-term value creation.
Approximately $520 million (36% of shares) repurchased since January 2024, with 52% repurchased since January 2021, returning significant capital to shareholders.
Operating costs reduced by eliminating the external management agreement, cutting management fees by 81% and aligning executive compensation with shareholder returns.
Sale of non-core assets, including Paysafe and System1, to realize a $55 million tax refund in Q2 2026 and provide liquidity for future investments.
Board and management collectively own over 14% of shares, representing the largest shareholder group.
Voting matters and shareholder proposals
Shareholders are urged to vote “FOR” only the four nominated directors on the WHITE proxy card at the December 12, 2025 Annual Meeting.
Carronade’s nominees are criticized for lacking relevant experience and for proposing governance changes that could disrupt board oversight.
Carronade seeks to control a new Strategic Review Committee, potentially undermining the full Board’s authority.
Board of directors and corporate governance
Since February 2024, three new independent directors have joined, serving on key committees, and the Board declassification process has begun.
An independent Chair and new CEO have been appointed to strengthen Board independence and oversight.
The Board’s unique strength is sourcing proprietary investment opportunities, which could be disrupted by electing Carronade’s nominees.
Latest events from Cannae
- $630M D&B sale, $323M buybacks, and sports focus marked 2025; earnings call set for Feb 23, 2026.CNNE
Q4 202523 Feb 2026 - Q2 net loss of $155M, $222M+ returned to shareholders, and major portfolio realignment.CNNE
Q2 20242 Feb 2026 - Q3 net loss narrowed to $13.6M, NAV is $2.1B, and shares trade at a 37% discount.CNNE
Q3 202414 Jan 2026 - Q4 revenue fell 8% year-over-year, but portfolio growth and capital returns remain strong.CNNE
Q4 202423 Dec 2025 - Strategic investments and leadership in football assets drive growth; shareholders urged to vote.CNNE
Proxy Filing8 Dec 2025 - Board recommends voting for nominees with proven expertise to ensure long-term value creation.CNNE
Proxy Filing1 Dec 2025 - Contested election, board declassification, and internalization drive governance overhaul.CNNE
Proxy Filing1 Dec 2025 - Affirmed long-term value strategy, capital returns, and board alignment with shareholders.CNNE
Proxy Filing1 Dec 2025 - Strategic plan advances with DNB sale, major buybacks, and focus on private investments.CNNE
Proxy Filing1 Dec 2025